Getting ready for the next charge ♉

Special lineup tomorrow                                                                                                                                                                                                                                                                                                                                                                                                                 September 29, 2024 | [Read Online]( Getting ready for the next charge ♉ Special lineup tomorrow 🚨[SAJ BLOWOUT ends soon]( I 🎯[mañana]( Just some reminders for this coming week — I’ll be hosting a special guest in the [Market Master’s Trading Room]( at 11am EST MONDAY (tomorrow) during my normal Bullseye session. JW starts promptly at 9am too so call out sick from work and join us! And Jason’s [NEW $2000 Small Account Journey]( is starting on Tuesday — lowest price I can ever recall for this top-rated service. Good for any level of options trader! I hope you’ve had a great weekend. For some, weekends are a time to rest and recharge 🔋. I try to get in my share of that too, but as someone who thousands of people look to for trading ideas and education, I also carve out time to prepare my battle plan for the week ahead. That’s a lot easier when my Cowboys play on a Thursday like they did this week (or when they’re racking up losses like the last two weeks). Me, last weekend. Right now, I’m laser-focused on a company that’s changing the game on drug discovery and development using… wait for it… take a guess… AI! It seems like everybody is getting in the AI game now, but not everyone is producing results that matter. That’s not the case with this company, which counts 19 of the top 20 pharmaceutical companies worldwide as clients. It also received the prestigious 2024 Impact Award from InterSystems in a field of more than 1,000 client projects. If that doesn’t tell you that the company is making an impact, consider that it is already producing significant revenue with impressive year-over-year growth. That’s more than you can say for a great many companies in the biopharma space. The stock is trading at an attractive price right now, and I think we could see a flurry of activity tomorrow. I'm hoping this will be another winner like some of the fast-moving stocks I've recently alerted that have gained 30%, 70%, even 200% or more after I discussed them with you. This is one you certainly don't want to miss out on. I’m doing a deep-dive on this company right now and will post the things that stand out to me on [this page here]( at 9am EST tomorrow. And to receive any updates throughout the day, be sure you’re on my world-famous SMS list by texting “RAGE” to 1- (888) 404-5747 📲. I’ll be in touch in the morning with this red-hot idea to start your trading week. To Your Success, P.S. If you’re confused about where to start with any of our services, why not give Davis a call today? He’d be happy to help you try to find the best fit (1-800-585-4488 / davis@ragingbull.com).  Questions or concerns about our products? Email Support@ragingbull.com © Copyright 2022, RagingBull  DISCLAIMER To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull.com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. [tw]( Update your email preferences or unsubscribe [here]( © 2024 Bullseye Trades 62 Calef Hwy. #233 Lee, NH 03861, United States of America [Terms of Service](